Filing Details
- Accession Number:
- 0001104659-20-007181
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-27 16:52:34
- Reporting Period:
- 2020-01-23
- Accepted Time:
- 2020-01-27 16:52:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1760542 | Hookipa Pharma Inc. | HOOK | Pharmaceutical Preparations (2834) | 815395687 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1768216 | Anders Lilja | C/O Hookipa Pharma Inc. 350 Fifth Avenue, 72Nd Floor, Suite 7240 New York NY 10118 | Sr. Vp, Technical Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-01-23 | 4,075 | $0.10 | 4,075 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-01-23 | 4,075 | $12.17 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-01-23 | 7,568 | $0.10 | 7,568 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-01-23 | 7,568 | $12.81 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-01-23 | 4,075 | $0.00 | 4,075 | $0.10 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-01-23 | 7,568 | $0.00 | 7,568 | $0.10 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2026-12-31 | No | 4 | M | Direct | |
| 13,098 | 2026-12-31 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.6265 to $12.9584, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- This option is fully vested and exercisable.
- 25% of this option vested and became exercisable on January 1, 2018, with the remainder vesting in 12 equal quarterly installments thereafter.
Billionaire Hedge Funds
